FDA Warns of Possible Chantix Heart Risks
The smoking-cessation drug Chantix may carry a slightly higher risk for heart problems, according to the Food and Drug Administration (FDA). The finding was announced by the FDA as a result of a large combined analysis of clinical trials for the drug. The meta-analysis studied data for 7,002 patients, some of whom received Chantix (varenicline) while the others received a placebo. The analysis established